http://bit.ly/2AbPxuj

The USFDA stated that Goa facility may be subject to regulatory or administrative action and that it may withhold approval of any pending applications or supplements in which this facility is listed.

from Markets http://bit.ly/2K3sM1v

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads